Home Other Building Blocks 402615-91-2
402615-91-2,MFCD18251416
Catalog No.:AA00C0TP

402615-91-2 | racFTY720 Phosphate

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
≥98%
in stock  
$152.00   $106.00
- +
5mg
≥98%
in stock  
$668.00   $467.00
- +
10mg
≥98%
in stock  
$1,180.00   $826.00
- +
25mg
≥98%
in stock  
$2,579.00   $1,805.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA00C0TP
Chemical Name:
racFTY720 Phosphate
CAS Number:
402615-91-2
Molecular Formula:
C19H34NO5P
Molecular Weight:
387.4507
MDL Number:
MFCD18251416
SMILES:
CCCCCCCCc1ccc(cc1)CCC(COP(=O)(O)[O-])(CO)[NH3+]
Properties
Computed Properties
 
Complexity:
409  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
26  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
4  
Rotatable Bond Count:
14  
Undefined Atom Stereocenter Count:
1  
XLogP3:
0.8  

Literature

Title: Elevated Nuclear and Cytoplasmic FTY720-Phosphate in Mouse Embryonic Fibroblasts Suggests the Potential for Multiple Mechanisms in FTY720-Induced Neural Tube Defects.

Journal: Toxicological sciences : an official journal of the Society of Toxicology 20160301

Title: Discovery of A-971432, An Orally Bioavailable Selective Sphingosine-1-Phosphate Receptor 5 (S1P5) Agonist for the Potential Treatment of Neurodegenerative Disorders.

Journal: Journal of medicinal chemistry 20151210

Title: FTY720 Phosphate Activates Sphingosine-1-Phosphate Receptor 2 and Selectively Couples to Gα12/13/Rho/ROCK to Induce Myofibroblast Contraction.

Journal: Molecular pharmacology 20150601

Title: ASP4058, a novel agonist for sphingosine 1-phosphate receptors 1 and 5, ameliorates rodent experimental autoimmune encephalomyelitis with a favorable safety profile.

Journal: PloS one 20140101

Title: Sphingosine and FTY720 are potent inhibitors of the transient receptor potential melastatin 7 (TRPM7) channels.

Journal: British journal of pharmacology 20130301

Title: The sphingosine-1-phosphate receptor agonist FTY720 and its phosphorylated form affect the function of CD4+CD25+ T cells in vitro.

Journal: International journal of molecular medicine 20120701

Title: LC-MS/MS determination of FTY720 and FTY720-phosphate in murine intracellular compartments and human plasma.

Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20120301

Title: Fast simultaneous quantitative analysis of FTY720 and its metabolite FTY720-P in human blood by on-line solid phase extraction coupled with liquid chromatography-tandem mass spectrometry.

Journal: Journal of pharmaceutical and biomedical analysis 20120125

Title: Kinetic analysis of autotaxin reveals substrate-specific catalytic pathways and a mechanism for lysophosphatidic acid distribution.

Journal: The Journal of biological chemistry 20110826

Title: Engagement of S1P₁-degradative mechanisms leads to vascular leak in mice.

Journal: The Journal of clinical investigation 20110601

Title: Plasma gelsolin modulates cellular response to sphingosine 1-phosphate.

Journal: American journal of physiology. Cell physiology 20101201

Title: (S)-FTY720-vinylphosphonate, an analogue of the immunosuppressive agent FTY720, is a pan-antagonist of sphingosine 1-phosphate GPCR signaling and inhibits autotaxin activity.

Journal: Cellular signalling 20101001

Title: Removal of sphingosine 1-phosphate receptor-3 (S1P(3)) agonism is essential, but inadequate to obtain immunomodulating 2-aminopropane-1,3-diol S1P(1) agonists with reduced effect on heart rate.

Journal: Journal of medicinal chemistry 20100422

Title: Phosphorylation of the immunomodulator FTY720 inhibits programmed cell death of fibroblasts via the S1P3 receptor subtype and Bcl-2 activation.

Journal: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 20100101

Title: Utilization of the Tango beta-arrestin recruitment technology for cell-based EDG receptor assay development and interrogation.

Journal: Journal of biomolecular screening 20091001

Title: Different response patterns of several ligands at the sphingosine-1-phosphate receptor subtype 3 (S1P(3)).

Journal: British journal of pharmacology 20090401

Title: Accumulation of fingolimod (FTY720) in lymphoid tissues contributes to prolonged efficacy.

Journal: The Journal of pharmacology and experimental therapeutics 20090301

Title: Sphingosine 1-phosphate receptor agonism impairs skin dendritic cell migration and homing to secondary lymphoid tissue: association with prolonged allograft survival.

Journal: Transplant immunology 20081101

Title: Anticancer activity of FTY720: phosphorylated FTY720 inhibits autotaxin, a metastasis-enhancing and angiogenic lysophospholipase D.

Journal: Cancer letters 20080808

Title: Selective activation of G alpha i mediated signalling of S1P3 by FTY720-phosphate.

Journal: Cellular signalling 20080601

Title: A novel sphingosine 1-phosphate receptor agonist, 2-amino-2-propanediol hydrochloride (KRP-203), regulates chronic colitis in interleukin-10 gene-deficient mice.

Journal: The Journal of pharmacology and experimental therapeutics 20080101

Title: Functional consequences of S1P receptor modulation in rat oligodendroglial lineage cells.

Journal: Glia 20071201

Title: Neither intravenous nor intracerebroventricular administration of obestatin affects the secretion of GH, PRL, TSH and ACTH in rats.

Journal: Regulatory peptides 20070201

Title: Synthesis and biological evaluation of gamma-aminophosphonates as potent, subtype-selective sphingosine 1-phosphate receptor agonists and antagonists.

Journal: Bioorganic & medicinal chemistry 20070115

Title: A monoselective sphingosine-1-phosphate receptor-1 agonist prevents allograft rejection in a stringent rat heart transplantation model.

Journal: Chemistry & biology 20061101

Title: Novel immunomodulator FTY720 is phosphorylated in rats and humans to form a single stereoisomer. Identification, chemical proof, and biological characterization of the biologically active species and its enantiomer.

Journal: Journal of medicinal chemistry 20050811

Title: Synthesis of 4(5)-phenylimidazole-based analogues of sphingosine-1-phosphate and FTY720: discovery of potent S1P1 receptor agonists.

Journal: Bioorganic & medicinal chemistry letters 20050801

Title: A rational utilization of high-throughput screening affords selective, orally bioavailable 1-benzyl-3-carboxyazetidine sphingosine-1-phosphate-1 receptor agonists.

Journal: Journal of medicinal chemistry 20041230

Title: Potent S1P receptor agonists replicate the pharmacologic actions of the novel immune modulator FTY720.

Journal: Bioorganic & medicinal chemistry letters 20040621

Title: Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes.

Journal: The Journal of pharmacology and experimental therapeutics 20040501

Title: Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate.

Journal: The Journal of biological chemistry 20040402

Title: The immune modulator FTY720 targets sphingosine 1-phosphate receptors.

Journal: The Journal of biological chemistry 20020614

Title: Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists.

Journal: Science (New York, N.Y.) 20020412

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 402615-91-2
Tags:402615-91-2 Molecular Formula|402615-91-2 MDL|402615-91-2 SMILES|402615-91-2 racFTY720 Phosphate